Suite 300
1620 29 Street NW
Calgary, Alberta T2N 4L7

Telephone: 403·284·5444
DSL: 403·284·9410
Fax: 403·284·9633
Pharmacy: 403·284·5401
Pharmacy Fax: 403·284·5430

Print this page




 
The IVF/ICSI Program

Luteal Phase Support / Early Pregnancy Follow-Up

In order to support the endometrial lining at time of implantation and early pregnancy, supplemental progesterone is given. Progesterone can be given as a vaginal suppository, gel, capsules or intramuscular injection. If the pregnancy test is positive, progesterone is continued until the tenth week of pregnancy.

Medications/Side Effects

Common side effects include vaginal dryness, vaginal itching, nausea, headache, depression, changes in vaginal secretions, breast tenderness, and fluid retention.

Notify your doctor if you experience severe headache, vomiting, dizziness, trouble breathing, pain/swelling/warmth or redness in the lower legs, fainting, chest pain or visual changes as this could indicate the development of ovarian hyperstimulation syndrome (OHSS).

Pregnancy

Following a positive pregnancy test, an early ultrasound (6-8 weeks gestation) is recommended. Luteal Phase Support with Progesterone is continued until 10 weeks gestation. As the Regional Fertility Program is exclusively devoted to fertility the clinic does not provide prenatal care or obstetrical care. Patients should arrange obstetrical follow-up with their family doctor or obstetrician. Following a negative outcome, all medications are stopped and a follow-up appointment should be booked to discuss cycle outcome and future treatment options.